{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:32:38Z","timestamp":1766086358588},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,9,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>There are currently no oral or topical agents approved by government regulation agencies for the management of premature ejaculation (PE).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To review pharmacologic therapies for treatment of PE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The Sexual Medicine Society of North America hosted a State of the Art Conference on Premature Ejaculation on June 24\u201326, 2005 in collaboration with the University of South Florida. The purpose was to have an open exchange of contemporary research and clinical information on PE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measure<\/jats:title>\n                  <jats:p>Data were obtained by extensive examination of peer-reviewed published literature.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Chronic administration of selective serotonin reuptake inhibitors (SSRIs) is associated with an increased adverse event profile encompassing dry mouth, nausea, drowsiness, and reduced libido. Their use may also facilitate the development of other sexual dysfunctions, such as anejaculation and erectile dysfunction (ED). Phosphodiesterase-5 (PDE-5) inhibitors have also been investigated for the management of PE, as an indirect consequence of their ability to prolong erections. Trials have found PDE-5 inhibitors to be appropriate for men with PE secondary to ED, or when they are used in conjunction with other agents such as SSRIs. Trials of topical formulations that contain either anesthetic agents or other ingredients report significant increases in ejaculatory latency times; however, long-term safety and efficacy studies are lacking. New agents are being developed specifically for the management of PE. Among these are a topical formulation and numerous oral agents. Only one agent\u2014dapoxetine hydrochloride (DPX)\u2014has undergone Phase III trials. DPX is a serotonin transport inhibitor (STI) with a pharmacokinetic profile conducive to on-demand dosing for the management of PE. Unlike the current oral agents, DPX has a rapid onset of action and is effective from the first dose.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Well-designed clinical trials utilizing appropriate outcome measurements are needed to provide safe and effective pharmacologic options for men with PE.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2006.00309.x","type":"journal-article","created":{"date-parts":[[2006,8,29]],"date-time":"2006-08-29T08:26:50Z","timestamp":1156840010000},"page":"332-341","source":"Crossref","is-referenced-by-count":27,"title":["Current and Future Pharmacotherapies of Premature Ejaculation"],"prefix":"10.1093","volume":"3","author":[{"given":"Wayne J.G.","family":"Hellstrom","sequence":"first","affiliation":[{"name":"Department of Urology, Tulane University School of Medicine , New Orleans , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,9,1]]},"reference":[{"key":"2024032600172304900_bib1","first-page":"743","article-title":"Utility of selective serotonin reuptake inhibitors in premature ejaculation","volume":"5","author":"Waldinger","year":"2004","journal-title":"Curr Opin Invest Drugs"},{"key":"2024032600172304900_bib2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00004714-199808000-00004","article-title":"Effect of SSRI antidepressants on ejaculation: A double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline","volume":"18","author":"Waldinger","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"2024032600172304900_bib3","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2004.05.005","article-title":"On-demand treatment of premature ejaculation with clomipramine and paroxetine: A randomized, double-blind fixed-dose study with stopwatch assessment","volume":"46","author":"Waldinger","year":"2004","journal-title":"Eur Urol"},{"key":"2024032600172304900_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/sj.ijir.3901384","article-title":"Safety and efficacy of citalopram in the treatment of premature ejaculation: A double-blind placebo-controlled, fixed dose, randomized study","volume":"18","author":"Safarinejad","year":"2006","journal-title":"Int J Impot Res"},{"key":"2024032600172304900_bib5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/01485010290099192","article-title":"Serum leptin levels in patients with premature ejaculation","volume":"48","author":"Atmaca","year":"2002","journal-title":"Arch Androl"},{"key":"2024032600172304900_bib6","first-page":"51","article-title":"Understanding ejaculatory disorders","volume":"13","author":"Shenassa","year":"2001","journal-title":"Contemp Urol"},{"key":"2024032600172304900_bib7","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1176\/ajp.151.9.1377","article-title":"Paroxetine treatment of premature ejaculation: A double-blind, randomized, placebo-controlled study","volume":"151","author":"Waldinger","year":"1994","journal-title":"Am J Psychiatry"},{"key":"2024032600172304900_bib8","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1046\/j.1464-410X.1997.00102.x","article-title":"Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: A double-blind, randomized, dose\u2013response study","volume":"79","author":"Waldinger","year":"1997","journal-title":"BJU"},{"key":"2024032600172304900_bib9","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/S0022-5347(05)68816-7","article-title":"Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies","volume":"161","author":"McMahon","year":"1999","journal-title":"J Urol"},{"key":"2024032600172304900_bib10","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/S0022-5347(01)65467-3","article-title":"The efficacy of fluoxetine in the treatment of premature ejaculation: A double-blind placebo controlled study","volume":"156","author":"Kara","year":"1996","journal-title":"J Urol"},{"key":"2024032600172304900_bib11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.ju.0000071040.12407.32","article-title":"Comparison of the efficacy and safety of 90 mg versus 20 mg fluoxetine in the treatment of premature ejaculation","volume":"170","author":"Manasia","year":"2003","journal-title":"J Urol"},{"key":"2024032600172304900_bib12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00004714-199510000-00006","article-title":"Sertraline treatment for premature ejaculation","volume":"15","author":"Mendels","year":"1995","journal-title":"J Clin Psychopharmacol"},{"key":"2024032600172304900_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.ijir.3900344","article-title":"Treatment of premature ejaculation with sertraline hydrochloride","volume":"10","author":"McMahon","year":"1998","journal-title":"Int J Impot Res"},{"key":"2024032600172304900_bib14","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/S0022-5347(01)63201-4","article-title":"Treatment of premature ejaculation with sertraline hydrochloride: A single-blind placebo controlled crossover study","volume":"159","author":"McMahon","year":"1998","journal-title":"J Urol"},{"key":"2024032600172304900_bib15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0090-4295(99)00187-9","article-title":"Short-term analysis of the effects of as needed use of sertraline at 5 pm for the treatment of premature ejaculation","volume":"54","author":"Kim","year":"1999","journal-title":"Urology"},{"key":"2024032600172304900_bib16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0022-5347(01)63940-5","article-title":"Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: A double-blind, placebo controlled study","volume":"159","author":"Kim","year":"1998","journal-title":"J Urol"},{"key":"2024032600172304900_bib17","first-page":"402","article-title":"A double-blind crossover trial of clomipramine for rapid ejaculation in 15 couples","volume":"59","author":"Althof","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"2024032600172304900_bib18","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/S0022-5347(01)65576-9","article-title":"Clomipramine and sexual function in men with premature ejaculation and controls","volume":"156","author":"Haensel","year":"1996","journal-title":"J Urol"},{"key":"2024032600172304900_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/00926239908403982","article-title":"Clomipramine in the treatment of rapid (premature) ejaculation","volume":"25","author":"Strassberg","year":"1999","journal-title":"J Sex Marital Ther"},{"key":"2024032600172304900_bib20","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/sj.ijir.3901161","article-title":"Predicting responsiveness to the treatment of rapid ejaculation with 25 mg clomipramine as needed","volume":"16","author":"Rowland","year":"2004","journal-title":"Int J Impot Res"},{"key":"2024032600172304900_bib21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1743-6109.2005.20351.x","article-title":"Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation","volume":"2","author":"McMahon","year":"2005","journal-title":"J Sex Med"},{"key":"2024032600172304900_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2605.2002.00368.x","article-title":"Management of premature ejaculation\u2014A comparison of treatment outcome in patients with and without erectile dysfunction","volume":"25","author":"Chia","year":"2002","journal-title":"Int J Androl"},{"key":"2024032600172304900_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0090-4295(02)02075-7","article-title":"Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation","volume":"61","author":"Chen","year":"2003","journal-title":"Urology"},{"key":"2024032600172304900_bib24","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1016\/S0022-5347(05)64174-2","article-title":"A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation","volume":"168","author":"Salonia","year":"2002","journal-title":"J Urol"},{"key":"2024032600172304900_bib25","first-page":"520","article-title":"Comparison between sildenafil plus sertraline and sertraline alone in the treatment of premature ejaculation","volume":"11","author":"Zhang","year":"2005","journal-title":"Zhongua Nan Ke Xue"},{"key":"2024032600172304900_bib26","first-page":"239","article-title":"Tadalafil and slow-release fluoxetine in premature ejaculation\u2014A prospective study","volume":"173","author":"Mattos","year":"2005","journal-title":"J Urol"},{"key":"2024032600172304900_bib27","first-page":"338","article-title":"Are PDE5-inhibitors a men\u2019s health pill?","volume":"173","author":"Sommer","year":"2005","journal-title":"J Urol"},{"key":"2024032600172304900_bib28","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.urology.2005.09.002","article-title":"Comparison of efficacy of sildenafil-only, sildenafil plus topical EMLA cream, and topical EMLA-cream-only in treatment of premature ejaculation","volume":"67","author":"Atan","year":"2006","journal-title":"Urology"},{"key":"2024032600172304900_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.ijir.3901011","article-title":"Topical lidocaine-prilocaine spray for the treatment of premature ejaculation: A proof of concept study","volume":"15","author":"Henry","year":"2003","journal-title":"Int J Impot Res"},{"key":"2024032600172304900_bib30","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1464-410X.2003.04773.x","article-title":"Topical anaesthetic use for treating premature ejaculation: A double-blind, randomized, placebo-controlled study","volume":"93","author":"Busato","year":"2004","journal-title":"BJU Int"},{"key":"2024032600172304900_bib31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0090-4295(99)00415-X","article-title":"Clinical study of SS-cream in patients with lifelong premature ejaculation","volume":"55","author":"Choi","year":"2000","journal-title":"Urology"},{"key":"2024032600172304900_bib32","first-page":"239","article-title":"Monoaminergic transporter binding and inhibition profile of dapoxetine, a medication for the treatment of premature ejaculation","volume":"173","author":"Gengo","year":"2005","journal-title":"J Urol"},{"key":"2024032600172304900_bib33","first-page":"Abstract","article-title":"Pharmacokinetics of single and multiple escalating doses of dapoxetine in healthy volunteers","volume":"32","author":"Dresser","year":"2004","journal-title":"Clin Pharmaco Therap"},{"key":"2024032600172304900_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0022-5347(18)35971-8","article-title":"Dapoxetine for the treatment of premature ejaculation: Lack of interaction with PDE5 inhibitors","volume":"173","author":"Dresser","year":"2005","journal-title":"J Urol"},{"key":"2024032600172304900_bib35","article-title":"The effect of food on the pharmacokinetics of dapoxetine, a new on-demand treatment for premature ejaculation","author":"Dresser","year":"17\u201320, 2005"},{"key":"2024032600172304900_bib36","first-page":"239","article-title":"Dapoxetine for the treatment of premature ejaculation: Lack of interaction with ethanol","volume":"173","author":"Modi","year":"2005","journal-title":"J Urol"},{"key":"2024032600172304900_bib37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0022-5347(18)35972-X","article-title":"Efficacy and tolerability of dapoxetine in the treatment of premature ejaculation","volume":"173","author":"Pryor","year":"2005","journal-title":"J Urol"},{"key":"2024032600172304900_bib38","author":"Anafranil\u00ae","year":"2005"},{"key":"2024032600172304900_bib39","author":"Paxil\u00ae","year":"2005"},{"key":"2024032600172304900_bib40","author":"Prozac\u00ae","year":"2005"},{"key":"2024032600172304900_bib41","author":"Zoloft\u00ae"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515314648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515314648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/3\/Supplement_4\/332\/47737342\/jsm_3_supplement_4_332.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/3\/Supplement_4\/332\/47737342\/jsm_3_supplement_4_332.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T01:11:38Z","timestamp":1711415498000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/3\/Supplement_4\/332\/6883140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,1]]},"references-count":41,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2006,9,1]]},"published-print":{"date-parts":[[2006,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2006.00309.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,9]]},"published":{"date-parts":[[2006,9,1]]}}}